Research Papers

9 of 9 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Crosstalk between the JAK2 and TGF-β1 signaling pathways in scleroderma-related interstitial lung disease targeted by b…
Wang D; Wei Y; Xu L; Zhang J.
Adv Rheumatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
COVID-19 was not associated or trigger disease activity in spondylarthritis patients: ReumaCoV-Brasil cross-sectional d…
Marques CDL; Ribeiro SLE; Albuquerque CP; de Sousa Studart SA; Ranzolin A; de Andrade NPB; Dantas AT; Mota GD; Resende GG; Marinho AO; Angelieri D; Andrade D; Ribeiro FM; Omura F; Silva NA; Rocha Junior L; Brito DE; Fernandino DC; Yazbek MA; Souza MPG; Ximenes AC; Martins ASS; Castro GRW; Oliveira LC; Freitas ABSB; Kakehasi AM; Gomides APM; Reis Neto ET; Pileggi GS; Ferreira GA; Mota LMH; Xavier RM; de Medeiros Pinheiro M; ReumaCoV-Brasil Registry.
Adv Rheumatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Measurement properties of the Brazilian online version of the Fibromyalgia Rapid Screening Tool (FiRST).
de Sousa AP; de Arruda GT; Pontes-Silva A; de Souza MC; Driusso P; Avila MA.
Adv Rheumatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Factors associated with hospitalizations for Covid-19 in patients with rheumatoid arthritis: data from the Reumacov Bra…
Gomides APM; de Albuquerque CP; da Mota LMH; Devidé G; Dias LH; Duarte ALBP; Giovelli RA; Karnopp TE; de Lima HD; Marinho A; de Oliveira MS; Omura F; Ranzolin A; Resende G; Ribeiro FM; Ribeiro SLE; de Carvalho Sacilotto N; Dos Santos WG; Shinjo SK; de Sousa Studart SA; Teixeira FPS; Yazbek MA; Ferreira GA; Monticielo OA; Paiva E; Pileggi GCS; Dos Reis-Neto ET; de Medeiros Pinheiro M; Marques CDL; ReumaCoV Brasil Registry.
Adv Rheumatol (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): a Brazilian cohort.
Cavalcanti A; Islabão A; Magalhães C; Veloso S; Lopes M; do Prado R; Aquilante B; Terrazas AM; Rezende MF; Clemente G; Terreri MT.
Adv Rheumatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumato…
Tavares ACFMG; de Melo AKG; Cruz VA; de Souza VA; de Carvalho JS; Machado KLLL; de Azevedo Valadares LD; Dos Reis Neto ET; de Rezende RPV; de Resende Guimarães MFB; Ferreira GA; de Sousa Braz A; de Abreu Vieira RMR; de Medeiros Pinheiro M; Ribeiro SLE; Bica BEGR; Baptista KL; da Costa IP; Marques CDL; Lopes MLL; Martinez JE; Giorgi RDN; da Mota LMH; da Rocha Loures MAA; Dos Santos Paiva E; Monticielo OA; Xavier RM; Kakehasi AM; Pileggi GCS.
Adv Rheumatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic disease…
Pileggi GS; Ferreira GA; Reis APMG; Reis-Neto ET; Abreu MM; Albuquerque CP; Araújo NC; Bacchiega AB; Bianchi DV; Bica B; Bonfa ED; Borba EF; Brito DCSE; Duarte ÂLBP; Santo RCE; Fernandes PR; Guimarães MP; Gomes KWP; Kakehasi AM; Klumb EM; Lanna CCD; Marques CDL; Monticielo OA; Mota LMH; Munhoz GA; Paiva ES; Pereira HLA; Provenza JR; Ribeiro SLE; Junior LFR; Sampaio CSJC; Sampaio VS; Sato EI; Skare T; de Souza VA; Valim V; Lacerda MVG; Xavier RM; Pinheiro MM.
Adv Rheumatol (Unknown)
Published: 2021
4/6 Transparent
Registered Funding Declared
Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflamma…
Ruscitti P; Conforti A; Cipriani P; Giacomelli R; Tasso M; Costa L; Caso F.
Adv Rheumatol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Severe COVID-19: what have we learned with the immunopathogenesis?
Bordallo B; Bellas M; Cortez AF; Vieira M; Pinheiro M.
Adv Rheumatol (Unknown)
Published: 2020
2/6 Transparent
Funding Declared